About
Bio
Impact Factor:
4.798 (Source: Thomson Reuters Journal Citation Reports 2015)
Journal Ranking:
28/253 Pharmacology & Pharmacy (Source: Thomson Reuters Journal Citation Reports 2015)
Circulation:
A figure is not disclosed.
Distribution:
It is available via subscription.
Aims of the Journal:
The journal evaluates molecules, signal pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and should not include clinical information on specific drugs. Expert Opinion on Therapeutic Targets is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on novel molecular targets, with the aim of providing expert opinion on the scope for future drug development and the impact on drug discovery. Editors welcome reviews covering novel disease targets at the molecular level and their implications for future drug development and original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugs.
Readership:
Scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D.
Manuscript Submission:
Information for contributors can be found here and here.
Other information:
There is no generic email address. The Editorial Board can be found here.
Email
email@cision.one
Website
site@cision.one
Social media
Location
United Kingdom
Frequency
upgrade
Circulation
upgrade
Sectors
Pharmaceuticals, Science
Bio
Impact Factor: 4.798 (Source: Thomson Reuters Journal Citation Reports 2015) Journal Ranking: 28/253 Pharmacology & Pharmacy (Source: Thomson Reuters Journal Citation Reports 2015) Circulation: A figure is not disclosed. Distribution: It is available via subscription. Aims of the Journal: The journal evaluates molecules, signal pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and should not include clinical information on specific drugs. Expert Opinion on Therapeutic Targets is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on novel molecular targets, with the aim of providing expert opinion on the scope for future drug development and the impact on drug discovery. Editors welcome reviews covering novel disease targets at the molecular level and their implications for future drug development and original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugs. Readership: Scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D. Manuscript Submission: Information for contributors can be found here and here. Other information: There is no generic email address. The Editorial Board can be found here.
Website
Social media
Location
Frequency
Circulation
Sectors
Pharmaceuticals, Science
Most recent articles by Expert Opinion on Therapeutic Targets
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to Expert Opinion on Therapeutic Targets
-
TThe New York Times
The New York Times is an American daily news organization headquartered in New York City. It produces national and international journalism across print and digital platforms, covering topics including politics, business, technology, science, culture, and global affairs. The organization maintains a global network of bureaus and correspondents that contribute reporting from the United States and abroad. It publishes a daily print edition and continuously updates its digital platforms throughout the day with breaking news and feature reporting.
ViewAAxiosAxios is a website which focused on delivering clear, concise, and fact-based reporting on the most important topics shaping the world. The outlet covers politics, business, technology, science, health, climate, and culture, aiming to keep readers informed quickly and accurately.
ViewTThe New YorkerCreated in 1925 as a forum to discuss current ideas and events in metropolitan America. Its editorial content is a combination of domestic and international news analysis, along with cartoons and features pertaining to contemporary American living. Regular issue features include criticism of culture, sports, the arts and fashion as well as fiction, biographical portraits, a letters section and a listing of New York's activities. Originally founded as a weekly, he magazine is now published 47 times annually, with five of these issues covering two-week spans.
ViewTThe AtlanticDesigned as a news magazine written for upscale readers who have a high degree of intelligence and critical capacity and are interested in contemporary trends in finance, politics, the arts, literature, books, cuisine, public and foreign affairs, science and technology, culture, food and travel. Editorial content is aimed at the serious reader and is comprised of reflective pieces and non-fiction that provide different perspectives on what is occurring in contemporary society. The magazine was founded as The Atlantic Monthly in Boston, MA, in 1857. It was created as a literary and cultural commentary magazine. It quickly achieved a national reputation, which it held for more than a century. It was important for recognizing and publishing new writers and poets, and encouraging major careers. It published leading writers' commentary on abolition, education, and other major issues in contemporary political affairs. The magazine's founders were a group of prominent writers of national reputation, who included Harriet Beecher Stowe, Ralph Waldo Emerson, Henry Wadsworth Longfellow, Oliver Wendell Holmes, Sr., John Greenleaf Whittier and James Russell Lowell. Lowell was its first editor.
ViewCCNN OnlineInternet version of the worldwide cable news network providing live, ongoing coverage of news around the globe 24 hours a day. Regular features spotlight public affairs, news, politics, science, technology, business, food, medicine, fashion, sports, lifestyle, parenting and entertainment. The site also emphasizes topical and in-depth interviews and discussions with newsmakers, politicians, celebrities and people in the news. CNN.com has a content partnership with Health.com. Health.com stories will appear on the CNN.com website, however Health.com reporters are not employed by CNN and are better contacted through Health.com directly.
ViewUse CisionOne to find more relevant outletsContact Expert Opinion on Therapeutic Targets and get access to over 850K accurate, up-to-date media profiles.
Discover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.